Ceribell (CBLL) EBITDA (2023 - 2026)

Ceribell has reported EBITDA for 4 years, with the latest figure at -$19.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 55.5% year-over-year to -$19.9 million; the trailing twelve-month figure through Mar 2026 stood at -$60.3 million (down 34.96% YoY), and the FY2025 full-year result was -$53.3 million, down 31.64% from the prior year.
• EBITDA for Q1 2026 stood at -$19.9 million, down from -$13.5 million in the prior quarter.
• The five-year high for EBITDA was -$7.2 million in Q3 2023, with the low at -$19.9 million in Q1 2026.
• Historically, EBITDA has averaged -$11.7 million across 4 years, with a median of -$12.6 million in 2024.
• Annual changes were most pronounced in 2025 — EBITDA declined 7.4% — and 2026, when it tumbled 55.5%.
• Ceribell's EBITDA stood at -$8.4 million in 2023, then sank by 50.05% to -$12.6 million in 2024, then declined by 7.4% to -$13.5 million in 2025, then sank by 47.17% to -$19.9 million in 2026.
• The last three EBITDA figures came in at -$19.9 million (Q1 2026), -$13.5 million (Q4 2025), and -$13.3 million (Q3 2025), per Business Quant data.